Arch Dis Child Fetal Neonatal Ed 85:F18-F22 doi:10.1136/fn.85.1.F18
  • Original article

Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature

  1. J Hartmanna,
  2. A Husseina,
  3. E Trowitzscha,
  4. J Beckerb,
  5. K-H Henneckeb
  1. aDepartment of Pediatric Cardiology, Vestische Kinderklinik, University of Witten-Herdecke, Dr-Friedrich-Steiner- Str 5, 45711-Datteln, NRW, Germany, bNeonatal Intensive Care Unit and Perinatal Center
  1. Dr Hartmann, Klinik für angeborene Herzfehler, Herz- und Diabeteszentrum NRW, Universiteit Bochum, Georgstr 11, D-32545-Bad Oeynhausen, Germanyjhartmann{at}
  • Accepted 26 January 2001


BACKGROUND Thrombosis is a relatively rare event in children. However, many conditions in the neonatal period result in an increased risk of thrombus formation. The major risk factor is the indwelling intravascular catheter. Numerous small studies have reported experience of thrombolytic treatment for neonatal thrombotic disease with a wide range of different thrombolytic agents in various forms of administration, dosage, and duration, but no conclusions on the most effective treatment for neonates has been reached.

OBJECTIVE To assess the efficacy and safety of thrombolytic treatment of neonatal catheter related thrombus (CRT) formation with recombinant tissue plasminogen activator (rt-PA).

METHOD Over a six year period, 14 neonates with CRT were treated with the same rt-PA protocol (an initial bolus of 0.7 mg/kg over 30–60 minutes followed by infusion of 0.2 mg/kg/h).

RESULTS Complete clot dissolution was documented in 11 patients, and partial clot lysis in two patients, leading to a patency rate of 94%. In two cases, local bleeding occurred, resulting in treatment failure in one case. Finally, antithrombin III substitution was required in one case. No other complications such as severe bleeding were recognised.

CONCLUSION With the use of close clinical and haematological monitoring on a neonatal intensive care unit combined with serial two dimensional colour echocardiography, the present rt-PA protocol was shown to be a safe and effective method of clot dissolution in neonates.


    Latest from Education & Practice

    Latest from Education & Practice

    Register for free content

    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Fetal & Neonatal.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    Navigate This Article